Physician profile
India M Warner
NPI 1649827643
$1,934.63
in general payments reported to CMS, 2019-2025
22 companies · $21.54 in 2025
The $21.54 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $961 · 2023: $657 · 2024: $186 · 2025: $21.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $888.31 | 2022-2025 | |
| Janssen Biotech, INC. | $160.03 | 2022-2023 | Stelara, Simponi Aria, Simponi |
| E.R. Squibb & Sons, L.L.C. | $116.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.91 | 2022-2024 | Xifaxan |
| Novo Nordisk INC | $94.04 | 2021 | |
| Kite Pharma, INC. | $89.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.27 | 2022-2023 | Entyvio, Gattex |
| Bayer Healthcare Pharmaceuticals INC. | $60.96 | 2022 | |
| Genzyme Corporation | $45.89 | 2022-2024 | |
| Braintree Laboratories, INC. | $43.22 | 2022-2023 | Suflave |
| Pfizer INC. | $35.40 | 2023-2024 | |
| Celgene Corporation | $35.34 | 2022-2023 | Zeposia |
| Daiichi Sankyo INC. | $23.19 | 2023 | Enhertu |
| Lucid Diagnostics INC. | $20.82 | 2023 | |
| Lilly USA, LLC | $20.15 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $19.70 | 2023 | Dupixent |
| Sandoz INC. | $19.21 | 2023 | Hyrimoz |
| Gilead Sciences, INC. | $15.92 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.88 | 2023 | Linzess |
| Nestle Healthcare Nutrition INC. | $15.85 | 2023 | |
| Karyopharm Therapeutics INC. | $15.10 | 2021 | |
| Aimmune Therapeutics, INC. | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw India Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.